These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 27498821)
1. Lack of association between cytotoxic T-lymphocyte antigen-4 gene polymorphisms and lymphoid malignancy risk: evidence from a meta-analysis. Dai Z; Feng C; Zhang W; Liu J; Cao X; Zhang H; Liu Y; Wang M; Liu X; Dai Z Ann Hematol; 2016 Oct; 95(10):1685-94. PubMed ID: 27498821 [TBL] [Abstract][Full Text] [Related]
2. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis. Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350 [TBL] [Abstract][Full Text] [Related]
3. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies. Xia W; Shi R; Zheng WL; Ma WL Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791 [TBL] [Abstract][Full Text] [Related]
4. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies. Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045 [TBL] [Abstract][Full Text] [Related]
5. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis. Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617 [TBL] [Abstract][Full Text] [Related]
6. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis]. Yi B; Pei Y; Wang C; Jiang Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943 [TBL] [Abstract][Full Text] [Related]
7. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis. Zhao JJ; Wang D; Yao H; Sun DW; Li HY World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408 [TBL] [Abstract][Full Text] [Related]
8. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis. Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071 [TBL] [Abstract][Full Text] [Related]
9. CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to multiple sclerosis: a meta-analysis. Gyu Song G; Ho Lee Y Immunol Invest; 2013; 42(5):409-22. PubMed ID: 23802171 [TBL] [Abstract][Full Text] [Related]
10. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm. Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients. Zhu CL; Huang Q; Liu CH; Xie F Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308 [TBL] [Abstract][Full Text] [Related]
12. Association between cytotoxic T lymphocyte antigen-4 polymorphism and type 1 diabetes: a meta-analysis. Chen Z; Fei M; Fu D; Zhang L; Ma Y; Wang Y; Zhang F; Xia Q; Wang X Gene; 2013 Mar; 516(2):263-70. PubMed ID: 23261825 [TBL] [Abstract][Full Text] [Related]
13. Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis. Hu Y; Xu K; Jiang L; Zhang L; Shi H; Cui D Genet Test Mol Biomarkers; 2018 Apr; 22(4):224-236. PubMed ID: 29461867 [TBL] [Abstract][Full Text] [Related]
14. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens. Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis. Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262 [TBL] [Abstract][Full Text] [Related]
16. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome. Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409 [TBL] [Abstract][Full Text] [Related]
18. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis. Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372 [TBL] [Abstract][Full Text] [Related]
19. Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies. Chen M; Li S Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988065 [No Abstract] [Full Text] [Related]
20. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever. Gunesacar R; Erken E; Dinkci S Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]